Lee S K, Stevens L M, Anderson J P. "Method for the Synthesis of 182822-62-4
CP 141938
CP-141938
cis-N-[4-Methoxy-3-[[(2-phenyl-3-piperidinyl)amino]methyl]phenyl]-N-methylmethanesulfonamide
rel-N-[4-Methoxy-3-[[[(2R,3R)-2-phenyl-3-piperidinyl]amino]methyl]phenyl]-N-methyl-methanesulfonamide" [P]. US Patent, US 10021127 B2, 2019-10-27.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2021, 1284, (12), 4504-4532.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2016, 1156, (6), 3758-3784.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 182822-62-4
CP 141938
CP-141938
cis-N-[4-Methoxy-3-[[(2-phenyl-3-piperidinyl)amino]methyl]phenyl]-N-methylmethanesulfonamide
rel-N-[4-Methoxy-3-[[[(2R,3R)-2-phenyl-3-piperidinyl]amino]methyl]phenyl]-N-methyl-methanesulfonamide Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 1722, (4), 3779-3808.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2010, 1650, (1), 2672-2699.